4-(1,1-Dioxidothiomorpholino)benzoic acid → HCID 178523707, compound
Reaction equation
Cl.Cl.Cl.[O:4]1[C:12]2[CH:11]=[CH:10][N:9]=[C:8]([N:13]3[CH2:18][CH2:17][N:16]([CH2:19][CH2:20][C@H:21]4[CH2:26][CH2:25][C@H:24]([NH2:27])[CH2:23][CH2:22]4)[CH2:15][CH2:14]3)[C:7]=2[CH2:6][CH2:5]1.[O:28]=[S:29]1(=[O:44])[CH2:34][CH2:33][N:32]([C:35]2[CH:43]=[CH:42][C:38]([C:39](O)=[O:40])=[CH:37][CH:36]=2)[CH2:31][CH2:30]1>>[O:4]1[C:12]2[CH:11]=[CH:10][N:9]=[C:8]([N:13]3[CH2:18][CH2:17][N:16]([CH2:19][CH2:20][C@H:21]4[CH2:26][CH2:25][C@H:24]([NH:27][C:39](=[O:40])[C:38]5[CH:42]=[CH:43][C:35]([N:32]6[CH2:31][CH2:30][S:29](=[O:44])(=[O:28])[CH2:34][CH2:33]6)=[CH:36][CH:37]=5)[CH2:23][CH2:22]4)[CH2:15][CH2:14]3)[C:7]=2[CH2:6][CH2:5]1Participants
3
Procedure
The title compound, white solid (129 mg, 91%), MS (ISP) m/z=568.4 [(M+H)+], mp 261.5° C., was prepared in accordance with the general method of example 32 from trans-4-{2-[4-(2,3-dihydrofuro[3,2-c]pyridin-4-yl)-piperazin-1-yl]-ethyl}-cyclohexanamine trihydrochloride (intermediate C) (110 mg, 0.25 mmol) and 4-(1,1-dioxo-1λ6-thiomorpholin-4-yl)-benzoic acid.
Sources & evidence
- ORD record
- ord-d804715070e844e89eeec46852ca7cd8
- Source dataset
- uspto-grants-2013_11
- Patent number
- US08586579B2
Reaction notes
Loading…